TP53 and breast cancer: The obtained results indicated an insignificant variation in p53 expression between the breast cancer positive control group and GFAP implant group, while the presence of GFAP + PTX determined a notable variation of p53, suggesting the role of p53 as a tumor suppressor and mediator of programmed cell death [74].